Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
|
HEALTHY EXTRACTS INC. (Name of Issuer) |
Common Stock (Title of Class of Securities) |
42227D209 (CUSIP Number) |
Robert Madden PO Box 17207, Salt Lake City, UT, 84117 801-232-0753 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
07/19/2025 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 42227D209 |
| 1 |
Name of reporting person
Swanson Donald William | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
13,075,920.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
77.5 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock |
| (b) | Name of Issuer:
HEALTHY EXTRACTS INC. |
| (c) | Address of Issuer's Principal Executive Offices:
7375 COMMERCIAL WAY, SUITE 125, HENDERSON,
NEVADA
, 89011. |
| Item 2. | Identity and Background |
| (a) | Donald W Swanson |
| (b) | 7207 Coachlight St, Sarasota, FL 34243 |
| (c) | Self-employed Contractor |
| (d) | No |
| (e) | No |
| (f) | USA |
| Item 3. | Source and Amount of Funds or Other Consideration |
|
Assets and equity of Gummy USA, LLC merger with HYEX. | |
| Item 4. | Purpose of Transaction |
The securities were acquired in the Healthy Extracts Inc and Gummy USA, LLC merger. | |
| Item 5. | Interest in Securities of the Issuer |
| (a) | Donald W Swanson - 13,075,920 or 77.5% of the outstanding shares |
| (b) | Donald W Swanson - 13,075,920 or 77.5% of the outstanding shares |
| (c) | Donald W Swanson, July 19, 2025, 13,075,920 common stock, $1.80/share, Sarasota, FL. |
| (d) | None |
| (e) | N/A |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
There were no addition items included in the merger of company's. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|